6 completed. 3 Phase 2, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 3 | 3 | Completed 3 |
Follow Auris Medical AG: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| AM-125 in the Treatment of Acute Peripheral Vertigo Following Neurosurgery Intranasal Drug, Oral Tablet, Intranasal Placebo - Vestibular Vertigo | Phase 2 | Completed | Auris Medical AG | 124 | 2019-07-18 | 2023-09-14 |
| AM-111 in the Treatment of Acute Inner Ear Hearing Loss Placebo, AM-111 0.4 mg/ml, AM-111 0.8 mg/ml - Hearing Loss | Phase 3 | Completed | Auris Medical AG | 256 | 2015-11-01 | 2023-09-14 |
| AM-101 in the Treatment of Post-Acute Tinnitus 2 AM-101 - Tinnitus | Phase 3 | Completed | Auris Medical AG | 487 | 2014-06-01 | 2023-09-14 |
| AM-101 in the Treatment of Acute Tinnitus 3 AM-101, Placebo - Tinnitus | Phase 3 | Completed | Auris Medical AG | 893 | 2014-01-01 | 2023-09-14 |
| Efficacy of AM 101 in Patients With Acute Inner Ear Tinnitus AM-101 - Tinnitus | Phase 2 | Completed | Auris Medical AG | 248 | 2009-03-01 | 2013-02-13 |
| Efficacy of AM-111 in Patients With Acute Sensorineural Hearing Loss AM-111, placebo - Hearing Loss | Phase 2 | Completed | Auris Medical AG | 210 | 2008-12-01 | 2014-06-26 |
Tinnitus (3) · Hearing Loss (2) · Deafness (1) · Ear Diseases (1) · Hearing Disorders (1) · Hearing Loss, Noise-Induced (1) · Hearing Loss, Sensorineural (1) · Hearing Loss, Sudden (1) · Hearing Loss, Unilateral (1) · Otorhinolaryngologic Diseases (1) · Sensation Disorders (1) · Signs and Symptoms (1) · Speech Disorders (1) · Vertigo (1)
PDCD5 protein, rat (3) · D-JNKI-1 (2) · Administration, Intranasal (1) · Tablets (1)
Germany (4) · Bulgaria (1) · France (1)
Heinz Maier, MD (1)
2018 (1)